Skip to content

PR-Web

Press releases worldwide

  • Home
  • Contact
  • Datenschutzerklärung
  • Legal notice

Author: Firma RauCon

Live euroPLX 77 Brussels: „We’ve Met In Person Again!“

Posted on 29. November 202129. November 2021 by Firma RauCon Posted in General Tagged biopharma, business, deals, development, distribution, intermediate, licensing, marketing, nutraceutical, Opportunities, OTC, Partnering, pharma, prescription, Promotion

„Good That We’ve Finally Met In Person Again!“ was the most often heard remark by the attending Business Development Executives at the euroPLX 77 Brussels Marketplace for Pharma Business Opportunities, this year’s last important pharma industry partnering event which was […]

Read More

Singapore Entry Conditions Force Postponement of International Event

Posted on 28. October 2021 by Firma RauCon Posted in General Tagged api, biopharma, biotechnology, business, development, distribution, intermediate, licensing, marketing, nutraceutical, OTC, Partnering, pharma, prescription, Promotion

RauCon announces that the asiaPLX 1 Singapore Marketplace for Pharma Business Opportunities which was planned for 21 and 22 February 2022 will be postponed to spring 2023. This is owing to the restrictive entry conditions for travellers which prevent this […]

Read More

Las condiciones de la entrada en Singapur obligan a aplazar un evento internacional

Posted on 28. October 2021 by Firma RauCon Posted in General Tagged api, biopharma, biotechnology, business, development, distribution, intermediates, licensing, marketing, nutraceutical, OTC, Partnering, pharma, prescription, Promotion

Heidelberg, Alemania, 28 de Octubre de 2021. RauCon anuncia que el asiaPLX 1 Singapore Marketplace for Pharma Business Opportunities que estaba previsto para los días 21 y 22 de Febrero de 2022 se aplazará a la primavera de 2023. Las […]

Read More

asiaPLX 1 Singapore Marketplace for Pharma Business Opportunities (Networking | Singapore)

Posted on 27. October 2021 by Firma RauCon Posted in Events Tagged api, business, development, diagnostics, drugs, intermediates, licensing, marketing, nutraceuticals, OTC, pharma

The new Marketplace for Pharma Business Opportunities is attended by top business development executives of drug developing, producing or marketing companies from all over the world. Each Marketplace is an online exchange for pharma business opportunities and a platform to […]

Read More

El 77° Evento de Pharma Partnering se celebra finalmente en vivo!

Posted on 22. September 202122. September 2021 by Firma RauCon Posted in General Tagged Belgica, Bruselas, business, cooperation, development, digital, licensing, meeting, on site, online, Opportunities, opportunity, Partnering, partnership, pharma

El „Coronavirus Consultative Committee“ decidió flexibilizar las nuevas condiciones para Bélgica el 17 de Septiembre. Esto permitirá que euroPLX 77 Brussels, el 77º "Marketplace for Pharma Business Opportunities", se tendrá lugar en persona en los días 22 y 23 de […]

Read More

77th Pharma Partnering Event Live Again!

Posted on 22. September 202122. September 2021 by Firma RauCon Posted in General Tagged Belgium, Brussels, business, cooperation, development, digital, licensing, meeting, on site, online, Opportunities, opportunity, Partnering, partnership, pharma

After the Belgian „Coronavirus Consultative Committee“ set out new easing measures on 17 September the way has been cleared for euroPLX 77 Brussels, the 77th Marketplace for Pharma Business Opportunities to take place on-site in Brussels on 22 and 23 […]

Read More

RauCon Signs Second Partnership Agreement for Chinese Pharma Market

Posted on 2. July 20212. July 2021 by Firma RauCon Posted in General Tagged Asia, business, china, cooperation, development, digital, licensing, meeting, on site, online, Opportunities, opportunity, Partnering, partnership, pharma

After the recent signing of a partnership agreement for the mutual promotion of services with Lingmed Ltd., a company serving the Chinese healthcare market with intelligence databases, RauCon closed a second partnership agreement with GBI Group Ltd., a company which […]

Read More

euroPLX 79 Vienna Marketplace for Pharma Business Opportunities (Networking-Veranstaltung | Wien)

Posted on 2. July 2021 by Firma RauCon Posted in Events Tagged api, business, development, diagnostics, drugs, intermediates, licensing, marketing, nutraceuticals, OTC, pharma

This 79th Marketplace for Pharma Business Opportunities is an exchange for licenses, products, assets, distribution deals and other pharma business opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices. Flexible Partnering: Have an unlimited number of […]

Read More

euroPLX 78 Lisbon Marketplace for Pharma Business Opportunities (Networking-Veranstaltung | Cascais)

Posted on 2. July 2021 by Firma RauCon Posted in Events Tagged api, business, development, diagnostics, drugs, intermediates, licensing, marketing, nutraceuticals, OTC, pharma

This 78th Marketplace for Pharma Business Opportunities is an exchange for licenses, products, assets, distribution deals and other pharma business opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices. Flexible Partnering: Have an unlimited number of […]

Read More

euroPLX 76 Noordwijk Pharma Partnering sólo digital

Posted on 27. May 202128. May 2021 by Firma RauCon Posted in General Tagged business, cooperation, development, digital, farmacéutico, licensing, meeting, negocio, on site, online, Opportunities, opportunity, Partnering, pharma

Como las restricciones de Holanda en materia de eventos y el requisito de cuarentena para los participantes entrandos no se van a suavizar ni levantar antes de la mitad de Junio, el evento de Partnering Farmacéutico de euroPLX 76 Noordwijk, […]

Read More

Posts navigation

Older posts
Newer posts

Copyright 2016. All rights reserved.


Back To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more